Technology
EC revises objections against Apple payment policies
The European Commission raised revised objections with consumer technology giant Apple on Tuesday, over concerns around its App Store rules for music streaming providers.
PayPoint completes takeover of Appreciate Group
PayPoint announced the successful completion of the acquisition of Appreciate Group on Tuesday, having first announced the plans on 7 November last year.
Essensys ends first half in line with expectations
Workspace technology company Essensys reported a first half of trading in line with expectations in an update on Tuesday, with total revenue growing 18% to £12. 9m.
Kape directors reject cash offer made by Unikmind
Cybersecurity and privacy software company Kape Technologies updated the market on the cash offer made by Unikmind Holdings on Tuesday, with the independent directors rejecting the bid.
Haydale renews GEIC graphene partnership for sixth year
Haydale Graphene announced the renewal of its tier one partnership with the University of Manchester's Graphene Engineering Innovation Centre (GEIC) on Tuesday.
Slight dip in February Chicago PMI
Factory sector activity in the Chicago area slipped a tad in February, although the details were apparently less glum.
XP Power swings to loss despite H2 improvement, CFO resigns
Power control specialist XP Power reported a significant improvement in second-half performance in its results on Tuesday, as supply chain conditions stabilised, allowing for increased product shipments.
Benchmark makes strong start in first quarter
Aquaculture specialist Benchmark announced a strong start to the year on Tuesday, with growth reported in all of its business areas in the first quarter.
Directa Plus hikes forecasts after strong December
Graphene specialist Directa Plus upgraded its expectations for the full year in a trading update on Monday, after a strong performance in the final month of 2022.
Hutchmed enrols last patient in lymphoma treatment trial
Hutchmed China announced the completion of patient enrollment in a phase two registration trial of ‘amdizalisib’ on Monday, for the treatment of relapsed or refractory follicular lymphoma (FL), which is a subtype of non-Hodgkin's lymphoma.
GlobalData reports strong growth in revenue, profit
Industry intelligence specialist GlobalData reported strong growth in both revenues and profit for 2022 on Monday, with underlying revenue growth of 10% and total growth of 28% to £243. 2m.
CentralNic declares maiden dividend after record year
Internet company CentralNic reported a significant increase in revenue and profitability for 2022 on Monday.
Greencoat Renewables reports record full-year results
Greencoat Renewables reported a record year for 2022 on Monday, with strong financial and operational results.
Clean Power Hydrogen extends lock-in deals with CEO, shareholders
Clean Power Hydrogen (CPH2) announced on Monday that it has agreed amendments over the lock-ins with chief executive officer Jon Duffy and a number of other shareholders, including its founders, at the time of its admission to AIM in February last year.
Belluscura oxygen concentrator launched on GoodRx platform
Belluscura announced on Friday that its ‘X-PLOR’ portable oxygen concentrator (POC) was now available in the US through GoodRx, making it the first medical device in its field marketed through the digital healthcare platform.
CleanTech to pursue additional listing on ASX
Chile-focussed explorer and developer CleanTech Lithium announced its intention to pursue a listing on the official list of the Australian Securities Exchange (ASX) on Friday.
Tracsis reports strong first half of trading
Rail, traffic data and transport technology specialist Tracsis reported strong trading in a first-half update on Thursday, in line with expectations.
System1 reports record quarter for data revenue growth
Advertising and marketing technology company System1 reported a record-breaking quarter for data revenue growth in an update on Thursday.
Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth
Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.
Drax nearly doubles full-year profits, plans investment push
Drax Group nearly doubled its full-year operating profits even as it continued to invest heavily in the business.